Skip to main content

Influence of the Maternal Use of Labetalol on the Neurogenic Mechanism for Cerebral Autoregulation Assessed by Means of NIRS

  • Conference paper
  • First Online:
Oxygen Transport to Tissue XXXVI

Abstract

Labetalol is a drug used in the treatment of hypertensive disorders of pregnancy (HDP). In a previous study we investigated the influence of the maternal use of labetalol on the cerebral autoregulation (CA) mechanism of neonates. In that study, we found that labetalol induces impaired CA during the first day of life, with CA returning to a normal status by the third day after birth. This effect was hypothesized to be caused by labetalol-induced vasodilation. However, no strong evidence for this claim was found. In this study we aim to find stronger evidence for the vasodilation effect caused by labetalol, by investigating its effect on the neurogenic mechanism (NM) involved in CA. The status of the NM was assessed by means of transfer function analysis between the low frequency content of the autonomic control activity (LFA), obtained by processing of the heart rate (HR), and the regional cerebral oxygen saturation (rScO2). We found that neonates from mothers treated with labetalol presented a lower LFA and an impaired NM response during the first day of life, with values returning to normal by the end of the third day. These results reflect a vasodilation effect caused by labetalol, and indicate that the impaired CA observed in the previous study is caused by vasodilation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 229.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Magee LA, Elran E et al (2000) Risks and benefits of beta-receptor blockers for pregnancy hypertension: overview of the randomized trials. Eur J Obstetr Gynecol Reproduct Biol 88(1):15–26

    Article  CAS  Google Scholar 

  2. Haraldsson A, Geven W (1989) Half-life of maternal labetalol in a premature infant. Pharm Week Sci Ed 11(6):229–231

    Article  CAS  Google Scholar 

  3. Peng T, Rowley A, Ainslie PN et al (2008) Multivariate system identification for cerebral autoregulation. Ann Biomed Eng 36(2):308–320

    Article  PubMed  Google Scholar 

  4. Purkayastha S, Saxena A et al (2012) α1-Adrenergic receptor control of the cerebral vasculature in humans at rest and during exercise. Exp Physiol. doi:10.1113/expphysiol.2012.066118

    PubMed  Google Scholar 

  5. Caicedo A and Van Huffel S (2010) Weighted LS-SVM for function estimation applied to artifact removal in biosignal processing. Proceedings of the 32nd annual international conference of the IEEE Engineering in Medicine and Biology Society (EMBC 2010), Buenos Aires, Argentina, August 31–September 4, pp 988–991

    Google Scholar 

  6. Pichot V, Gaspoz JM et al (1999) Wavelet transform to quantify heart rate variability and to assess its instantaneous changes. J Appl Physiol 86:1081–1091

    Article  CAS  PubMed  Google Scholar 

  7. Schaffer L, Burkhardt T et al (2008) Cardiac autonomic balance in small-for-gestational-age neonates. Am J Physiol Heart Circ Physiol 294:H884–H890

    Article  CAS  PubMed  Google Scholar 

  8. Caicedo A, Thewissen L et al (2013) Effect of the maternal use of labetalol on the cerebral autoregulation in premature infants. Adv Exp Med Biol 789:105–111

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Research supported by a postdoctoral mandate of the KU Leuven (BOF-KU Leuven) and: Research Council KUL: GOA MaNet, PFV/10/002 (OPTEC), IDO 08/013 Autism, several PhD/postdoc & fellow grants. Flemish Government: FWO: PhD/postdoc grants, projects: G.0427.10N (Integrated EEG-fMRI), G.0108.11 (Compressed Sensing) G.0869.12N (Tumor imaging) G.0A5513N (Deep brain stimulation); IWT: TBM070713-Accelero, TBM080658-MRI (EEG-fMRI), TBM110697-NeoGuard, PhD Grants; iMinds 2013; Flanders Care: Demonstratieproject Tele-Rehab III (2012–2014). Belgian Federal Science Policy Office: IUAP P719/(DYSCO, `Dynamical systems, control and optimization', 2012–2017); ESA AO-PGPF-01, PRODEX (CardioControl) C4000103224. EU: RECAP 209G within INTERREG IVB NWE programme, EU HIP Trial FP7-HEALTH/ 2007–2013 (n° 260777), EU MC ITN Transact 2012 # 316679 y carito linda.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexander Caicedo .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media, LLC

About this paper

Cite this paper

Caicedo, A. et al. (2014). Influence of the Maternal Use of Labetalol on the Neurogenic Mechanism for Cerebral Autoregulation Assessed by Means of NIRS. In: Swartz, H.M., Harrison, D.K., Bruley, D.F. (eds) Oxygen Transport to Tissue XXXVI. Advances in Experimental Medicine and Biology, vol 812. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0620-8_23

Download citation

Publish with us

Policies and ethics